Skip to content

Madrigal Pharmaceuticals

US · MDGL #1355 by market cap Listed 2016
379.10 -17.64 -4.45%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
D-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Wolfe Research moved from Hold to Buy on 2026-08-04.

Analyst consensus 9 analysts

Buy
Avg price target 702.33 +85.3%
Price target rangecurrent 379.10
Low479.00
Avg702.33
High962.00
Buy 89% Hold 11% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 H.C. Wainwright -- Buy 620.00
2026-11-09 BofA Securities -- Hold 479.00
2026-11-04 CCORF -- Buy 633.00
2026-11-04 Wells Fargo -- Buy 685.00
2026-11-04 BofA Securities -- Hold 479.00
2026-11-04 Truist Financial -- Buy 743.00
2026-11-04 Citi -- Buy 760.00
2026-11-04 H.C. Wainwright -- Buy 620.00
2026-11-04 Barclays -- Buy 962.00
2026-11-03 Citi -- Buy 760.00
2026-10-29 CCORF -- Buy 612.00
2026-10-19 BofA Securities -- Hold 533.00
2026-10-16 Wells Fargo -- Buy 685.00
2026-10-15 UBS -- Buy 735.00
2026-10-14 UBS -- Buy 735.00
2026-10-12 Wells Fargo -- Buy 685.00
2026-10-08 H.C. Wainwright -- Buy 620.00
2026-09-30 Barclays -- Buy 962.00
2026-09-24 Goldman Sachs -- Buy 704.00
2026-09-23 Citi -- Buy 725.00
2026-08-11 CCORF -- Buy 612.00
2026-08-04 Wolfe Research -- Buy 605.00
2026-08-03 Barclays -- Buy 962.00
2026-07-31 Truist Financial -- Buy 709.00
2026-07-31 H.C. Wainwright -- Buy 620.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-08-04 Wolfe Research Hold → Buy 605.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 -- ±13.90% -8.08% (in line)
2026/Q2 2026-07-30 -- ±11.57% -9.83% (in line)
2026/Q1 2026-05-06 -- ±9.99% +7.42% (in line)
2025/Q4 2026-02-19 -- ±6.71% -11.11% (beat)
2025/Q3 2025-11-04 -- ±13.94% +7.83% (in line)
2025/Q2 2025-08-05 -- ±10.86% +8.59% (in line)
2025/Q1 2025-05-01 -- ±13.18% -1.86% (in line)
2024/Q4 2025-02-26 -- ±15.36% +14.99% (in line)
2024/Q3 2024-10-31 -- ±18.10% +20.10% (beat)
2024/Q2 2024-08-07 -- ±13.17% -12.18% (in line)
2024/Q1 2024-05-07 -- ±9.55% -7.48% (in line)
2022/Q1 2022-05-09 -- ±16.92% -10.14% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Madrigal Pharmaceuticals discussion 0 comments

Add a comment